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Abstract
Background: Papillomaviruses (PVs) establish a persistent infection in the proliferating basal cells of the epithelium. 
The viral genome is replicated and maintained as a low-copy nuclear plasmid in basal keratinocytes. Bovine and 
human papillomaviruses (BPV and HPV) are known to utilize two viral proteins; E1, a DNA helicase, and E2, a 
transcription factor, which have been considered essential for viral DNA replication. However, growing evidence 
suggests that E1 and E2 are not entirely essential for stable replication of HPV.
Results: Here we report that multiple HPV16 mutants, lacking either or both E1 and E2 open reading frame (ORFs) and 
the long control region (LCR), still support extrachromosomal replication. Our data clearly indicate that HPV16 has a 
mode of replication, independent of viral trans-factors, E1 and E2, which is achieved by origin activity located outside 
of the LCR.
Background
Papillomaviruses (PVs) infect the basal layers of epithelial
cells and maintain their genomes at constant, but rela-
tively low-copy number in basal epithelial cells. These
viruses replicate their genomes as nuclear plasmids in
their natural mammalian host cells. Understanding of
Human papillomavirus (HPV) replication has lagged
behind that of other DNA viruses due to the need for
development of efficient cell culture systems [1-3]. Most
of our knowledge of HPV replication is derived from
extensive studies of BPV1 in established rodent cell lines
(C127), since BPV1 was found to transform and replicate
episomally in these cells. Short-term replication assays
were performed in transformed cells, in order to identify
the cis- and trans-elements that were required for replica-
tion of PVs [4]. Using this approach, with BPV1, the early
proteins E1 and E2 were found to be required for viral
DNA replication [5-7]. These viral proteins interact with
their cognate binding sites, located within the LCR,
referred to as the origin of replication (ori). More detailed
analyses have shown that the minimal BPV origin
includes multiple E2BSs, an E1BS, and also an AT-rich
region [8].
Genetic analysis of HPV11 and 18 transient replication
also suggested that both viral proteins E1 and E2, as well
as the origin of replication containing one or more E2BS
and putative E1BS and AT-rich region, were essential for
HPV DNA replication [7,9-12]. Several experiments,
including those performed by cell-free DNA replication,
revealed that E1 had ATP-dependent helicase activity and
recruits DNA polymerase α to the viral ori to initiate rep-
lication. Efficient replication also depends on all other
DNA replication proteins; DNA polymerase δ and 7, pro-
liferating cell nuclear antigen (PCNA), replication protein
A (RPA), and topoisomerases I and II, that are provided
by the host cell [13,14].
Although it is apparent that the minimal requirement
for HPV replication is analogous to that for BPV1 in tran-
siently transfected cells, HPV16 genomic DNA has been
shown to replicate at lower efficiency than other HPVs
[6]. Furthermore, results from cell free replication assays
with various combinations of ori and viral proteins
showed certain differences in replication between BPV
and HPV. Variations in the viral replication efficiency
observed with cell extracts from different sources might
reflect dissimilar function of HPV with different host cel-
lular replication machinery [14].
Published data that indicated a requirement for E1 and
E2 proteins among PVs was mostly from transient trans-
fection assays that were performed in the context of exog-
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enously expressed viral proteins. The concentrations
used in those experiments would not reflect physiological
levels of the viral proteins in the basal layer of epithelial
cells in natural host tissue. Since the viral life cycle is
tightly linked to the differentiation status cell in the epi-
thelial compartment, it is conceivable that HPVs may
have more than one mode of DNA replication, so as to
allow fine-tuning of the viral copy number. In fact, recent
data has shown that an E1-independent mode of replica-
tion exists in the viral replication at an early stage of the
viral life cycle [15,16]. This result is in agreement with
previous experiments in Saccharomyces cerevisiae show-
ing that various HPVs can support viral replication in the
absence of both E1 or E2 proteins [17]. Moreover, the cis-
acting elements required for E1 and E2 -independent rep-
lication and maintenance were also mapped outside the
LCR region [18]. These findings lead us to hypothesize
that at certain point of the viral life cycle, the HPV repli-
cation may not require both of the viral trans-factors, E1
and E2, but may rely solely on cellular replication
machinery.
In this study, we analyzed the requirement for E1 and
E2 in HPV16 DNA replication at the early stage of the
viral life cycle. Using a short-term replication assay, as
previously used for BPV and HPVs [5,6], we have found
that HPV16 is able to replicate independently of viral
trans-factors, E1 and E2. We present evidence that
HPV16 possesses a distinct origin of replication-activity,
located in a region outside of the viral LCR that is not
recognized by the viral proteins, E1 and E2. However,
replication of HPV16 DNA in the absence of heterolo-
gously expressed E1 and E2 proteins is relatively low com-
pared to the E1 and E2-mediated replication. This is
consistent with a low, maintenance level of replication. In
contrast to previous results from transient transfection
and cell free system [5,7], we observed species and cell-
type specificity to HPV16 DNA replication under condi-
tions in which E1 and E2 were omitted.
Results
Transient replication of HPV16 genomic DNA in different 
cell lines
In order to determine the requirement for viral trans-fac-
tors in HPV16 DNA replication, different mammalian
cell lines of epithelial or fibroblast lineage were examined
for the ability to support transient viral DNA replication.
Baby Hamster Kidney cells (BHK), monkey kidney cells
(Vero), human osteoblasts (U2OS), human cervical cells
(C33A), and adenovirus 5-transformed human kidney
epithelial cells (293) were transfected with 5 μg o f a plas-
mid containing an entire HPV16 genome. At 4 days after
transfection, low-molecular-weight DNA was harvested
and subjected to DpnI digestion. Input DNA propagated
by DAM+ bacteria is methylated at adenine bases within
the GATC sequence, and is thus sensitive to DpnI diges-
tion, whereas DNA replicated in mammalian cells loses
the adenine methylation and thus, becomes DpnI-resis-
tant. The replicated DNAs were detected as full-length
plasmids by Southern analysis using pUC19 as a probe.
Human 293 and C33A demonstrated the ability to sup-
port viral DNA replication at a low level, whereas BHK,
Vero, and U2OS failed to replicate under the same condi-
tions (Figure 1). Variation in viral DNA replication in dif-
ferent cell lines clearly indicates a degree of species and/
or cell-type specificity in HPV16 replication. This also
reflected the greater reliance of HPV16 on the host repli-
cation machinery when E1 and E2 were not exogenously
supplemented.
Analysis of HPV16 E1- and E2-independent mode of 
replication
Based on the observation of E1-independent HPV repli-
cation in previous studies in yeast and mammalian cells,
we speculated that HPV16 may not entirely require either
E1 or E2 proteins for at certain early points in the viral life
cycle. To investigate the necessity for E1 and E2 in HPV16
DNA replication, HPV16 mutants with deletions that
included the E1 and E2 ORFs were generated in the back-
ground of the entire viral genome in a pUC19 backbone.
Figure 1 Transient replication of HPV16 DNA in different cell 
types. Five μg of plasmid containing HPV16 genomic DNA were trans-
fected into various cell lines; baby hamster kidney cell (BHK), American 
green monkey kidney cell (Vero), human osteoblastoma cell (U2OS), 
human cervical carcinoma cell (C-33A) and human embryonic kidney 
cell (293). After 4 days of transfection, low molecular weight DNA was 
extracted from 1 × 107 cells by Hirt method. During extraction, 10 ng of 
pUC19 DNA was added as a "spiked plasmid" to monitor the recovery 
of the plasmid DNA from transfected cells and to test the complete-
ness of DpnI digestion. For the Southern analysis, 10% of Hirt-DNA was 
digested with HindIII to linearize the plasmid and 90% was digested 
with both HindIII and DpnI. The blot was probed with random-
primed32-P labeled pUC19 DNA. As a control, linearized plasmid con-
taining HPV16 at concentrations of 100 and 10 pg was loaded on the 
left-most lanes of the blot.Pittayakhajonwut and Angeletti Virology Journal 2010, 7:123
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The mutants, designated as ΔE1-E2#13 and ΔE1-E2#15
lack E1 and E2 sequences to differing extents, as shown in
Figure 2A. These deletion mutants were examined for
short-term replication using human epithelial cells, 293
and HPV-negative human cervical cells, C33A that were
previously shown to support the replication of wild type
(WT) HPV16. The transient replication assay most
closely mimics the early phase of the HPV life cycle, thus,
representing the initial viral DNA replication upon HPV
infection. Analysis of short-term replication of HPV16
mutants defines the cis- elements required for HPV repli-
cation at the establishment phase of the HPV life cycle.
Equal amounts of HPV16 mutants (0.6 pmole equivalent)
were transfected into 1.5 × 106 cells by the liposome
method. To compare replication efficiency, a plasmid
containing an entire HPV16 genome was transfected in
parallel under the same conditions. Low-molecular-
weight DNA was extracted at 4 days post-transfection
and analyzed for DpnI-resistant replicated DNA as
described above.
As shown in Figure 2B and 2C, a mutant with a deletion
that included the E1 and E2 ORFs, designated as ΔE1-
E2#13 (lanes 2) showed DNA replication at a level com-
parable to that of the WT HPV16 in either 293 or C33A
cells. A similar level of replication was also observed in a
mutant, ΔE1-E2#15 (lane 3) that lacks both of E1-E2 cod-
ing regions and part of the LCR, which contains the E1
and E2 binding sites at the origin of replication. These
results indicate that the viral proteins, E1 and E2, are not
absolutely necessary for the viral DNA replication. Thus,
it is likely that HPV16 has sequences outside of the LCR,
which provide a mode of replication that is not depen-
dent on viral trans-factors, but potentially analogous to
an autonomously replicating sequence (ARS).
To determine if HPV16 carries a distinct replication
activity that functions independently of E1 and E2 pro-
teins, a series of mutants with progressive deletions span-
ning the LCR to the E1 and E2 ORFs were constructed
and tested for ability to replicate in a transient transfec-
tion assay. The deletion mutants were created in a context
of a whole HPV16 genomic DNA in a pUC19 backbone.
The mutant, ΔLCR, contains a deletion (nt 7266 to 7904/
1 to 269) in the LCR sequence where E1 and E2 bindings
sites are located. In the ΔE1-E2 mutant, the whole E1 and
E2 ORFs (nt 269 to 4466) were deleted. The mutant,
ΔLCR-E2, contains a combination of deletions in the
ΔLCR and ΔLCR-E2 mutants, whereas the L1 mutant
contains only a 3'-segment of the L1 ORF (nt 6156 to
7265). The replication activities of these mutants were
analyzed in both C33A and 293 cells.
When we performed a transient transfection assay,
each mutant was found to replicate at a similar level to
that of WT HPV16 (Figure 3B and 3C, lanes 2 to 5),
whereas, the plasmid backbone without HPV16 DNA
sequences, PUCGFP, did not show any detectable DNA
replication in either 293 and C33A cells (Figure 3B and
3C, lane 6). Interestingly, the mutant containing only a
partial segment of L1 coding region was able to replicate
in both cell lines with efficiency comparable to those of
WT and other mutants. These observations not only con-
firm the existence of E1 and E2 independent mode of rep-
lication in HPV16 but also indicate that the virus has a
distinct replication function, outside of the LCR, the
activity of which is likely to be mediated only by cellular
replication machinery. Our data indicate that a viral-
trans-factor independent cis-replicating element may
reside in the late region of HPV16 genome (L2-L1 ORFs).
Discussion
HPVs establish their life cycle in the stratified epithelium
of skin or mucosa. The virus replicates and amplifies its
genome in two different stages, non-productive and pro-
ductive cycles. In the non-productive stage, the first
amplification replication occurs immediately after infec-
tion and the viral DNA is stably maintained in the undif-
ferentiated basal cells. Whereas the second amplification
replication, which increases the HPV DNA copy number
to several hundreds or thousands per cells, takes place
after differentiation of the host cell. Based on the knowl-
edge acquired by studies with BPV1, the early step in the
PV replication may occur at relatively low levels of E1 and
E2 proteins. This amplification is thought to be rapid and
transient, after which, the viral DNA is maintained at low
copy number during the maintenance phase and persists
in a latent stage.
It would be reasonable to suggest that during mainte-
nance phase, HPV keeps the levels of E1 and E2 and the
viral copy number low in the infected basal cells, so as to
evade cellular immune surveillance. It is also logical that
the virus may employ a different mode of replication,
which relies more on cellular replication machinery to
stably retain the genome as a nuclear plasmid in the pro-
liferating basal epithelial compartment. The virus repli-
c a t e s  o n c e  pe r  c e l l  g e n e r a t i o n  i n  t h e  p r e s e n c e  o f  l o w -
levels of E1, and later converts to random-choice replica-
tion, with multiple rounds of viral DNA replication per
cell generation, when E1 is highly expressed [19]. This
concept is also consistent with results of previous studies
which found that E1 was dispensable for PV replication,
under some conditions [15].
There are conflicting results concerning the require-
ment of E2 in replication of PVs. In some studies, E2 ORF
has been shown not to be necessary for replication while
others have found an absolute requirement of E2
[6,20,21]. The role of E2 in replication is not entirely clear.
E2 has been found to alleviate nucleosomal-mediated
repression of replication by altering the chromatin struc-
ture around the ori, thus allowing accessibility of cellularPittayakhajonwut and Angeletti Virology Journal 2010, 7:123
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Figure 2 Replication of HPV16 DNA independently of E1 and E2 proteins. (A) Maps of PA99GFP and its mutant derivatives. The top bar represents 
a linear map of the HPV16 genome with responsive eight ORFs shown in arrows and the LCR indicated by a gray bar. The lines below show HPV16 
segments, designated wild type (WT) and respective deletion mutants. PA99GFP contains an entire HPV16 DNA, an enhanced green fluorescent pro-
tein (EGFP) under a CMV promoter in a pUC19 backbone. The mutants ΔE1-E2-#13, ΔE1-E2#15, and ΔE1-E2#18 harboring HPV16 DNA sequenced de-
noted by solid bars were created from pPA99GFP as described in Materials and Methods. Autoradiograms of representative Southern blots show 
extrachromosomal DNA (HindIII-digested products) and replicated DNA (DpnI-resistant) from transient replication assays with WT HPV16 and mutants 
in C33A (B) or 293 (C). Cells were transfected with WT or mutant HPV16 DNA containing plasmids as indicated. At 4 days post-transfection, extrachro-
mosamal DNA were isolated from 1 × 107 cells. For Southern analysis, 10% of each sample was linearized with single cutting enzyme, HindIII and 90% 
was digested with HindIII and DpnI. Blots were hybridized with random-primed radiolabeled pUC19 DNA. The blots with HindIII digested DNA were 
exposed for 2 h whereas the ones with double digestion (HindIII + DpnI) were exposed for 4 days. The pUC19 backbone plasmid was used as the 
"spiked plasmid" to monitor the efficiency of plasmid recovery and completeness of DpnI digestion. The control DNA shown on the left, contains 1 ng,Pittayakhajonwut and Angeletti Virology Journal 2010, 7:123
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Figure 3 Transient replication of HPV16 mutants with LCR and E1-E2 deletions. (A) Schematic representation of PUCGFP comprising an EGFP in 
a pUC19 backbone. An entire sequence and partial fragments of HPV16 DNA shown in solid lines were inserted into PUCGFP at BamHI to generate 
WT and mutants designated ΔLCR, ΔE1-E2, ΔLCR-E2, and L1 as described in Materials and Methods. Replication efficiencies of the HPV16 WT and mu-
tants are evaluated by a transient transfection assay. Autoradiograms of representative Southern blots show replicated DNAs from transient transfec-
tion assays in C33A (B) and 293 (B). The assay was performed as described in Figure 2 legend. Ten pg to 1 ng of linear plasmid containing the entire 
HPV16 DNA, was loaded on the left-most lanes, as copy number controls.Pittayakhajonwut and Angeletti Virology Journal 2010, 7:123
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replication factors [22]. It also directs E1 to bind to the ori
DNA (which it normally has only low specificity for), this
cooperation leads to activation of DNA replication [23].
However, this function can be bypassed if E1 is expressed
at high levels [24]. Therefore, it appears that E2 plays
more of a facilitory role in E1-dependent DNA replica-
tion.
In our previous study, we mapped the cis-acting repli-
cation and maintenance signals in the HPV16 genome
that are required for long-term stability [25]. Those stud-
ies revealed that cis-elements in the late region (L2-L1
ORFs) function in E2-independent genome maintenance.
The same studies led us to hypothesize that E1-E2-inde-
pendent replication function also resides within the same
region of the HPV genome. In order to assess viral trans-
factor independent replication apart from other influ-
ences, we chose to do short-term replication assays
described in the present study.
In this study, we report the autonomous replication of
HPV16 containing plasmids in the absence of E1 and E2
ORFs or their protein products (Figures 1, 2 and 3). The
E1 and E2 ORF mutants were able to replicate at a level
comparable to WT. Similar results were obtained from
transient replication assays using HPV16 genome that
contains a deletion of the LCR and progressive deletions
extending from the LCR to E2 coding region. The level of
viral trans-factor-independent replication, is clearly
above background, thus, we conclude that it represents
an intrinsic activity of the HPV genome, separate from
the E1-dependent ori. Since E1 is a helicase that plays a
role in replication by recruiting DNA polymerase α and
unwinding DNA, we infer that such functions must be
substituted by cellular helicases, such as mini-chromo-
some-maintenance proteins (MCMs), and Werner and
Bloom helicases.
E1-E2 independent replication may contribute to a true
form of latency, in which the virus minimizes its expres-
sion of viral proteins in host cells and keeps the viral copy
number low by utilizing cellular replication proteins
under S phase control (Figure 4). A mechanism of DNA
replication that is controlled by the cell has been well
studied in EBV, whose DNA is replicated one time per S
phase in latently infected cells [26,27]. This mode of repli-
cation is achieved through replication licensing proteins,
MCMs an ORC, which are restricted to late mitosis and
G1 phase of cell cycle [28]. These proteins assemble on
the latent origin of replication, OriP, of EBV and are also
known to complex with the latent origin of replication of
KSHV DNA [29]. The low level of viral genome replica-
tion, as regulated by cellular factors, is a beneficial and
common strategy for episomal viruses to establish
latency. We suggest that HPV may adopt this mechanism
to control its genome replication in favor of DNA mainte-
nance during its persistence phase in the host. Based on
the similar magnitude of WT versus E1/E2 ORF mutants,
our results suggest that E1-E2-independent replication
may be the preferred mode of replication upon the initial
infection and that higher levels of E1 alter the mode of
replication later in the infectious process. However, we
cannot presently exclude the possibility that viral-trans-
factor independent replication occurs throughout the
viral lifecycle, even at the same time as E1-dependent
replication is ongoing.
To date, it is not clear whether the cellular DNA repli-
cation licensing proteins are associated or necessary for
replication in the absence of E1 and E2 with HPV16
DNA. It is interesting that E1, which is an ATP-depen-
dent helicase and origin-binding of HPV, has many simi-
larities to cellular MCM proteins. In fact, recent
preliminary work has shown that E1 directly interacts
with MCM2 and MCM6 of the MCM hexamer (Kenneth
Alexander, personal communication). Since this binding
is specific, it is likely that E1 and MCMs share conserved
structures that are interchangeable to form a hybrid-heli-
case hexamer at the origin of replication. This possibility
is currently under investigation. Our studies suggest that
E1-E2 independent replication may act to preserve a
latent-like state where MCMs are substituted for E1 and
replication is carried out by cellular proteins that control
the replication in once-per-cell cycle manner [19]. This
strict replication is overcome by expression of E1 that
switches replication to a multiple DNA copy per-cell-
cycle mode, perhaps by directly modifying MCM com-
plexes.
Under conditions in which E1 and E2 were not
expressed exogenously, WT HPV16 and all mutants,
Figure 4 A Model regulation of HPV copy number during the viral 
lifecycle. The yellow circle represents the viral episomes. During the 
maintenance phase, expression of E6 and E7 induces proliferation of 
basal keratinocytes and the viral genome is replicated extrachromoso-
mally at low-copy number (1-10 copies per cell). Little if any E1 and E2 
protein is expressed in the basal layer cells, which leads to theta-form 
replication of HPV genomes. As the cells differentiate, expression of E1 
and E2 trans-factors increases in the spinous layer. A transition from 
theta to rolling circle replication results in an increase in copy number 
up to 100-1000 copies per cell. Post-amplification, high levels of L1 and 
L2 capsid genes are expressed and capsid assembly occurs in the gran-
ular and squamous layers of the stratified epithelium. Progeny virus is 
released by desquamation.Pittayakhajonwut and Angeletti Virology Journal 2010, 7:123
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exhibited low-copy replication in human cervical cells
(C33A) and human embryonic kidney cells (293). This
result is in contrast to experiments in which ectopic
expression of E1 and E2 was provided, in which a wide
range of mammalian cells were reported to support LCR-
dependent replication [6,7,14]. Cell and species specific-
ity in viral replication have been reported in the other
members of the papovavirus family; SV40 and polyoma-
virus replication specificities rely on species-specific
interactions between large tumor antigen and the cellular
DNA polymerase α/primase complex and the single-
stranded DNA binding protein [30-32]. It is likely that the
replication restriction also exists for papillomaviruses. As
results demonstrated in this and previous studies [33,34],
variation of cell and tissue restriction for HPV replication
suggests that HPVs may rely to a greater degree on spe-
cific cellular factors than previously thought. This may
explain the strict host range of these viruses, which is, in
part, implicated by the presence of cellular factors neces-
sary for the initiation of DNA replication.
Our study demonstrates that E1-E2-independent HPV
DNA replication occurs by an alternative mechanism
directed to sites outside of the LCR. The replication effi-
ciency is relatively low and cell-type restricted, which
makes sense for a virus which spends much of its effort to
avoid immune surveillance. It is speculated that cellular
factors may play a dominant role in this mode of replica-
tion. Potential mechanisms that may account for E1-E2-
independent replication and maintenance may include
recruitment of transcription factors and/or recruiting of
cellular replication machinery by cellular proteins. Our
recent results suggest that cellular chromosomal segrega-
tion (centromeric, metaphase chromatin, and telomeric)
regulation proteins are reasonable candidates for this
role. Further dissection of the cis-and trans-acting com-
ponents that regulate E1-E2-independent HPV replica-
tion is required to understand its role in the context of
the viral life cycle.
Methods
Mammalian cells and transfection methods
American green monkey kidney; Vero, osteoblastoma;
U2OS, human embryonic kidney; 293, and human cervi-
cal carcinoma cells; C33A were grown in Dulbecco's
modified Eagle's medium (DMEM) supplemented with
10% fetal bovine serum and 1 mM sodium pyruvate in a
5% CO2 incubator at 37°C. Baby hamster kidney; BHK
cells, were cultured in DMEM supplemented with 5%
fetal bovine serum. All transfections were performed
with eqimolar amounts of plasmid DNA by the use of
Dreamfect reagent (Ozbiosciences). Cells were seeded at
the density of 1.5-2 × 106 cells in a 100 mm plate for 16 to
24 h prior to transfection.
Plasmids and library constructions
The PA99GFP plasmid contains a full-length HPV16
genome cloned into pUC19 with enhanced green fluores-
cent protein (EGFP) under the regulation of the cytomeg-
alovirus promoter. This plasmid was modified from
pPA99 [17] by insertion of EGFP gene which was PCR-
amplified from pGFP C1 using primers (5' primer: 5'-
GCATCCTCGAGGTAATCAATTACGGG-3' and 3'
primer: 5'-CGAAGCTTGAGCTCGAGATCTGAG-3')
containing XhoI site (bolded) into the XhoI site of pPA99.
Deletion mutants designated ΔE1-E2#13, ΔE1-E2#15 and
ΔE1-E2#18 which are indicated in Figure 2A, were
obtained from modifications of PA99GFP. The HPV16 E2
deletion mutants were made by cleavage of PA99GFP
with SexAI and XcmI. After the removal of SexAI-XcmI
fragment, the protruding ends were subsequently
repaired by DNA polymerase I (Klenow) and re-ligated.
The resultant plasmids were screened for ones that lack
the SexAI-XcmI fragment but retain the selectable
marker. Three plasmids were selected and subjected to
DNA sequencing analysis. The first one had a 3585 bp
deletion (nucleotides 339-3924) resulting in removal of
the E1 and E2 ORFs referred to as ΔE1-E2#13. The sec-
ond one, named ΔE1-E2#15, lacked HPV16 sequences
between nucleotides 7394-7904 and 1-3924 within the
LCR, E6, E7, E1 and E2 ORFs. For the last HPV16 E2
mutant, designated as ΔE1-E2#18, a deletion was created
between nucleotides 3661-5240, thus leaving E1 ORF
intact but truncating the E2 and L2 ORFs.
The HPV16GFP plasmid contains the entire HPV16
genome in pUCGFP that carries an expression cassette of
EGFP gene in a pUC19 backbone. HPV16 mutants desig-
nated ΔLCR-E2, ΔE1-E2, and L1 were derived from
HPV16GFP as previously described [25]. The mutant
ΔLCR was made by deleting a 909-bp fragment between
P m l I  a n d  B s a B I  s i t e s  a n d  t h e n  r e - l i g a t e d  b y  T 4  D N A
ligase. To confirm the deletion, DNA sequencing analysis
was performed afterward by standard procedures. A map
of HPV16GFP and its derivative constructs is shown in
Figure 3A.
Short-term DNA replication assays
Cells were seeded into a 100 mm dish at the density indi-
cated above and transfected with 0.6 pmoles of plasmid
DNA using the manufacturer's instructions. The plas-
mid-containing cells were grown under non-selective
conditions for 4 days prior to analysis. Plasmid DNA was
isolated using the Hirt method [35] from equal numbers
of cells (6 × 106 - 1 × 107 cells). Ten ng of pUC19, referred
to as "spiked DNA", was added to each sample prior to
cell lysis in order to monitor the efficiency of plasmid iso-
lation from cells and the completeness of subsequent
DpnI digestion. Approximately 10% of each sample was
digested with 10 U of a single-cutting enzyme, HindIII, atPittayakhajonwut and Angeletti Virology Journal 2010, 7:123
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37°C for 4 h, (resulting in over 90% completion of HindIII
digestion), followed by overnight digestion with 20 U
DpnI. Upon digestion, DNA was separated on a 0.8% aga-
rose gel and then transferred to a nitrocellulose mem-
brane. Blots were hybridized at 42°C overnight with a
pUC19 DNA probe radiolabeled by random priming kit
(GE Healthcare). Autoradiography was carried out by use
of a PhosphoImager (Bio-Rad) and quantified by the
Quantity One program (Bio-Rad). Relative replication
activities were quantified from a phosphorimage of the
Southern blots. The percentages of replicated DNA refer
to the ratio of the level of replicated DNA (DpnI-resistant
plasmid) over the level of HindIII-linearized plasmid. The
numbers were normalized against the level of the spiked
DNA in each sample.
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